Biotechnology Services Market worth $416.25 billion by 2030, growing at a CAGR of 11.60% - Exclusive Report by 360iResearch

The "Biotechnology Services Market by Service Type (Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services), End-Users (Biotechnology Companies, Clinical Research Organizations(CROs), Contract Manufacturers Organizations (CMOs)) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Biotechnology Services Market to grow from USD 193.05 billion in 2023 to USD 416.25 billion by 2030, at a CAGR of 11.60%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/biotechnology-services?utm_source=openpr&utm_medium=referral&utm_campaign=sample

The biotechnology services market entails a vast array of services, including DNA sequencing, proteomics, bioinformatics, drug discovery, and regulatory support services. The market pairs scientific expertise with advanced technologies to enhance, design, and produce novel biotechnological products and processes. Breakthroughs in gene editing, such as CRISPR, and enhancements in high-throughput sequencing are accelerating R&D processes, and growing investments in healthcare lead to an increased demand for new treatment modalities, which are the significant factors propelling the adoption of biotechnology services. However, the market faces certain constraints, such as high price tags for advanced biotechnological research and services, delayed project timelines due to the stringent and diverse regulations, and genetic research and manipulations that raise ethical debates that can affect public acceptance. However, growing demand for vaccines, monoclonal antibodies, other biologics, big data analytics, and artificial intelligence in gene sequencing and drug development are creating new opportunities for service providers. Personalized medicine-tailored therapies based on genetic profiles present significant market potential.

Market Segmentation & Coverage:

This research report categorizes the Biotechnology Services Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Service Type, market is studied across Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services, Prevention & Disease Control, Public Engagement Activities, and Tissue Collection. The Donor Recruitment is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Biotechnology Companies, Clinical Research Organizations(CROs), and Contract Manufacturers Organizations (CMOs). The Clinical Research Organizations(CROs) is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Biotechnology Services Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Biotechnology Services Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Biotechnology Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Almac Group Limited, AnaBioTec NV, Avance Clinical Pty Ltd., Azenta Life Sciences, Becton, Dickinson and Company, Biogen Inc., BioIVT LLC, Caidya, Catalent, Inc., Charles River Laboratories International, Inc., CMIC Group, Contract Pharmacal Corp., Crown Bioscience, Inc., Danaher Corporation, Eurofins Scientific Limited, GE HealthCare Technologies Inc., GenScript Biotech Corporation, ICON PLC, ITR Laboratories Canada, Kaneka Corporation, Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc..

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/biotechnology-services?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Biotechnology Services Market, by Service Type
7. Biotechnology Services Market, by End-Users
8. Americas Biotechnology Services Market
9. Asia-Pacific Biotechnology Services Market
10. Europe, Middle East & Africa Biotechnology Services Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Biotechnology Services Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Biotechnology Services Market?
3. What is the competitive strategic window for opportunities in the Biotechnology Services Market?
4. What are the technology trends and regulatory frameworks in the Biotechnology Services Market?
5. What is the market share of the leading vendors in the Biotechnology Services Market?
6. What modes and strategic moves are considered suitable for entering the Biotechnology Services Market?

Read More @ https://www.360iresearch.com/library/intelligence/biotechnology-services?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.